Michel Marre

14PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersBehavioural epidemiologyEpigenetics (incl. genome methylation and epigenomics)Digital electronic devicesExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 19, 2025
Lipoprotein levels and statin treatment related to dementia and cognitive decline in individuals with type 2 diabetes: an observational analysis from the ADVANCE study.

Peder Af Geijerstam, John Chalmers, Miriam Pikkemaat

|Dec 11, 2024
Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE Trial.

Toshiaki Ohkuma, Katie Harris, Mark Woodward

|Mar 14, 2024
Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study.

Leah E Cahill, Rachel A Warren, Allie S Carew

|Dec 05, 2023
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas.

Sarah Meulebrouck, Victoria Scherrer, Raphaël Boutry

|Dec 23, 2022
Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes.

Kamel Mohammedi, Michel Marre, Samy Hadjadj

|Jul 06, 2021
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control.

Johanne Tremblay, Mounsif Haloui, Redha Attaoua

Pageof 3

Frequent Collaborators

7 joint publications

Ronan Roussel

6 joint publications

Kamel Mohammedi

5 joint publications

Samy Hadjadj

5 joint publications

John Chalmers